In addition to functioning as a transcription factor, experimental observations suggest that AR is also a licensing factor for AR-positive and androgen-sensitive prostate cancer cells and associates with licensing proteins Orc2, Cdc-6, Cdt-1 and Mcm2 [4–6] . Here, AR is linked to prostate carcinoma.